Association of cardiovascular diseases, metabolic syndrome and obstructive sleep apnea: Data from 1,000 Japanease PSG cases

A. Matsuo, M. Kosaka, N. Kobayashi, T. Horiuchi, T. Agatsuma, A. Ushiki, S. Kanda, K. Keishi (Nagano, Matsumoto, Japan)

Source: Annual Congress 2012 - Metabolic and cardiovascular consequences of OSA II
Session: Metabolic and cardiovascular consequences of OSA II
Session type: Thematic Poster Session
Number: 3867
Disease area: Sleep and breathing disorders

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
A. Matsuo, M. Kosaka, N. Kobayashi, T. Horiuchi, T. Agatsuma, A. Ushiki, S. Kanda, K. Keishi (Nagano, Matsumoto, Japan). Association of cardiovascular diseases, metabolic syndrome and obstructive sleep apnea: Data from 1,000 Japanease PSG cases. Eur Respir J 2012; 40: Suppl. 56, 3867

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Genetic determinants of cardiovascular disease in patients with obstructive sleep apnea (OSA)
Source: International Congress 2015 – Ring of fire: inflammation and metabolism in sleep-disordered breathing
Year: 2015


Cardiovascular risk factors and the metabolic syndrome in patients with obstructive sleep apnea
Source: Annual Congress 2008 - Cardiovascular complications in obstructive sleep apnoea
Year: 2008

Obstructive sleep apnea and metabolic syndrome in 1,600 adult Japanease PSG cases.
Source: International Congress 2018 – Sleep and breathing control: phenotypes
Year: 2018

Association between obstructive sleep apnoea (OSA) severity and metabolic disturbances
Source: International Congress 2017 – Obstructive and central sleep apnoea: consequences and comorbidities
Year: 2017

Association of obstructive sleep apnea hypopnea syndrome with cardiovascular disease: a candidate gene association study
Source: Virtual Congress 2020 – Pathophysiology and treatment of obstructive sleep apnoea
Year: 2020


Transition from obstructive sleep apnea (OSA) to obesity hypoventilation syndrome (OHS)
Source: International Congress 2015 – Measuring sleep-disordered breathing in children and adults I: questionnaires, epidemiology and sleep studies
Year: 2015


Screening for obstructive sleep apnoea (OSA) in patients attending a hypertension clinic with features of the metabolic syndrome
Source: Annual Congress 2012 - Snoring and scoring: subjective and objective measures of sleep-disordered breathing
Year: 2012

Association between metabolic disturbances and inflammatory markers in obstructive sleep apnea (OSAS) patients
Source: Annual Congress 2008 - Metabolic syndrome and systemic inflammation in obstructive sleep apnoea
Year: 2008


Correlations between cardiovascular diseases and diabetes in obstructive sleep apnoea (OSA)
Source: Annual Congress 2012 - Metabolic and cardiovascular consequences of OSA I
Year: 2012

Prevalence of obstructive sleep apnea syndrome in patients with risk factors for cardiovascular diseases in a large population in Zaragoza (Spain)
Source: International Congress 2014 – Sleep disordered breathing 3
Year: 2014


Prevalence of obstructive sleep apnea syndrome (OSAS) in men varies markedly according to definition criteria
Source: International Congress 2016 – Comorbid sleep apnoea in specific clinical entities and differential diagnosis of sleep disorders
Year: 2016


Association between smoking and concomitant diseases in obstructive sleep apnoea (OSA)
Source: International Congress 2015 – To treat or not to treat? Sleep-disordered breathing II
Year: 2015

Association between daytime hypersomnolence and the metabolic syndrome in men with obstructive sleep apnea
Source: Annual Congress 2009 - Clinical aspects of sleep apnoea
Year: 2009

Asthma, obesity, metabolic dysfunction and obstructive sleep apnoea
Source: International Congress 2019 – State of the art session: Sleep and breathing disorders
Year: 2019


Prevalence of metabolic syndrome with obstructive sleep apnea in a Korean population
Source: Annual Congress 2013 –Sleep disordered breathing in special situations III
Year: 2013


Obstructive sleep apnea syndrome and cardiovascular diseases risk in patients with COPD
Source: Annual Congress 2012 - Physiology, heart failure and respiration in relation to OSA
Year: 2012


The prevalance of cardiovascular disorders in patients with obstructive sleep apnoea syndrome
Source: Eur Respir J 2002; 20: Suppl. 38, 293s
Year: 2002

Prevalence of metabolic syndrome in patients with hypertension and obstructive sleep apnea
Source: Annual Congress 2009 - Socio-economic and epidemiological aspects of sleep apnoea
Year: 2009

The investigation of relationship between red cell distribution width and cardiovascular diseases in patients with obstructive sleep apnea syndrome
Source: Annual Congress 2013 –Sleep disordered breathing in special situations I
Year: 2013

Cardiovascular risk, insulin resistance and metabolic syndrome in patients with obstructive sleep apnea
Source: Annual Congress 2007 - Metabolic consequences of obstructive sleep apnoea
Year: 2007